Selection for Androgen Receptor Mutations in Prostate Cancers Treated with Androgen Antagonist
摘要：
The role of androgen receptor (AR) mutations in androgen-independent prostate cancer (PCa) was determined by examining AR transcripts and genes from a large series of bone marrow metastases. Mutations were found in 5 of 16 patients who received combined androgen blockade with the AR antagonist flutamide, and these mutant ARs were strongly stimulated by flutamide. In contrast, the single mutant AR found among 17 patients treated with androgen ablation monotherapy was not flutamide stimulated. Patients with flutamide-stimulated AR mutations responded to subsequent treatment with bicalutamide, an AR antagonist that blocks the mutant ARs. These findings demonstrate that AR mutations occur in response to strong selective pressure from flutamide treatment.
展开
DOI：
10.1186/cc7393
被引量：
年份：
1999
Taylor & Francis
Semantic Scholar
万方医学
Semantic Scholar
(全网免费下载)
Europe PMC
查看更多
NCBI
NCBI
Oxford Univ Press
AACR
(全网免费下载)
AACR
JBC
AACR
(全网免费下载)
ResearchGate
ResearchGate
(全网免费下载)
EBSCO
escholarship.umassmed.edu
(全网免费下载)
pharmrev.aspetjournals.org
fasebj.org
scienceopen.com
mcb.asm.org
mcponline.org
mysciencework.com
intl.pharmrev.org
SAGE
perspectivesinmedicine.cshlp.org
escholarship.umassmed.edu
jme.endocrinology-journals.org
clinchem.org
mendeley.com
Semantic Scholar
(全网免费下载)
AACR
(全网免费下载)
AACR
(全网免费下载)
ResearchGate
(全网免费下载)
escholarship.umassmed.edu
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
